Archean Q4FY26 PAT Slumps; Logistics Costs Hit Margins
Archean Chemical Industries reported a steep decline in Q4FY26 consolidated net profit to ₹122.3mn from ₹537.5mn YoY, with total income dropping to ₹3,063.3mn. Management cited lower salt volumes, a 50% rise in fuel costs, and logistics disruptions in Kutch as key headwinds, though bromine realizations improved 14%. Full-year FY26 consolidated income grew 8% to ₹11,740.2mn. The company also announced the availability of the earnings call transcript and provided updates on its semiconductor facility in Odisha.

*this image is generated using AI for illustrative purposes only.
Archean Chemical Industries reported a steep year-on-year decline in profitability in Q4FY26, even as full-year consolidated revenue posted modest growth. The company's Q4FY26 consolidated net profit (Profit After Tax) fell to ₹122.3mn from ₹537.5mn in Q4FY25, reflecting significant pressure on the bottom line. Consolidated total income for Q4FY26 came in at ₹3,063.3mn, compared to ₹3,533.8mn in the year-ago quarter. For the full year FY26, consolidated total income grew 8% year-on-year to ₹11,740.2mn from ₹10,912.4mn in FY25. In a regulatory filing, the company announced that the audio recording of the earnings conference call held on May 13, 2026, is now available on its website.
Q4FY26 & FY26 Consolidated Financial Performance
Operational profitability saw a sharp contraction during Q4FY26. Consolidated EBITDA declined to ₹490.8mn from ₹961.0mn on a year-on-year basis. Finance costs rose sharply to ₹104.3mn in Q4FY26 from ₹2.9mn in Q4FY25, weighing heavily on the bottom line. For the full year FY26, consolidated EBITDA stood at ₹2,657.3mn against ₹3,514.4mn in FY25, while consolidated PAT for FY26 was ₹1,054.1mn compared to ₹1,621.4mn in FY25. The following table summarizes the key consolidated financial metrics:
| Metric: | Q4FY26 | Q4FY25 | FY26 | FY25 |
|---|---|---|---|---|
| Total Income: | ₹3,063.3mn | ₹3,533.8mn | ₹11,080.0mn | ₹10,783.0mn |
| EBITDA: | ₹490.8mn | ₹961.0mn | ₹2,657.3mn | ₹3,514.4mn |
| Profit Before Tax: | ₹158.6mn | ₹746.7mn | ₹1,471.0mn | ₹2,639.5mn |
| Profit After Tax: | ₹122.3mn | ₹537.5mn | ₹1,054.1mn | ₹1,621.4mn |
| Basic EPS (₹): | 1.13 | 4.33 | 8.66 | 13.13 |
Management Commentary on Q4 Performance
Management attributed the quarterly performance to a mixed demand environment and significant external headwinds. Industrial salt volumes for Q4FY26 stood at 1.1 million tons, down 7.2% year-on-year, impacted by customer deferrals and logistics challenges. Road construction in Kutch increased transportation distances, raising logistics costs by approximately ₹200 to ₹220 per ton by March 2026. Bromine volumes increased 4% year-on-year to 3,731 metric tons, with realization up 14% year-on-year due to pricing actions. However, the Middle East crisis led to a 50% increase in industrial fuel prices and an 18-20% rise in global freight costs.
Standalone Performance
On a standalone basis, Archean Chemical's Q4FY26 total income stood at ₹3,047.1mn versus ₹3,333.3mn in Q4FY25. Standalone EBITDA for Q4FY26 came in at ₹664.0mn compared to ₹1,011.2mn in Q4FY25. Standalone PAT for Q4FY26 was ₹297.6mn, down from ₹583.1mn in Q4FY25. For the full year FY26, standalone total income was ₹10,887.5mn against ₹10,634.5mn in FY25, while standalone PAT stood at ₹1,543.7mn compared to ₹1,849.2mn in FY25.
| Metric: | Q4FY26 | Q4FY25 | FY26 | FY25 |
|---|---|---|---|---|
| Total Income: | ₹3,047.1mn | ₹3,333.3mn | ₹10,887.5mn | ₹10,634.5mn |
| EBITDA: | ₹664.0mn | ₹1,011.2mn | ₹3,080.4mn | ₹3,721.2mn |
| Profit Before Tax: | ₹419.0mn | ₹795.8mn | ₹2,102.6mn | ₹2,899.5mn |
| Profit After Tax: | ₹297.6mn | ₹583.1mn | ₹1,543.7mn | ₹1,849.2mn |
| Basic EPS (₹): | 2.41 | 4.72 | 12.51 | 14.98 |
Subsidiary-wise Revenue and Profitability Contribution
The consolidated performance was supported by strong revenue growth from subsidiaries, particularly ACUME Chemicals, which reported total income of ₹830.5mn in FY26 versus ₹274.7mn in FY25, a growth of 202% year-on-year. The parent entity ACIL contributed ₹10,887.5mn in FY26, up 2% from ₹10,634.5mn in FY25. NEUN reported income of ₹5.2mn in FY26 against ₹2.7mn in FY25, a growth of 89%. However, at the EBITDA level, subsidiaries ACUME, IDEALIS, and NEUN remained loss-making, with ACUME reporting EBITDA of ₹-98.3mn in FY26 versus ₹-4.3mn in FY25, and IDEALIS reporting ₹-47.8mn versus ₹-75.8mn in FY25.
| Entity: | FY26 Total Income | FY25 Total Income | YoY Growth | FY26 EBITDA | FY26 PBT |
|---|---|---|---|---|---|
| ACIL: | ₹10,887.5mn | ₹10,634.5mn | 2% | ₹3,080.4mn | ₹2,102.6mn |
| ACUME: | ₹830.5mn | ₹274.7mn | 202% | ₹-98.3mn | ₹-421.8mn |
| IDEALIS: | ₹17.0mn | ₹0.5mn | — | ₹-47.8mn | ₹-150.4mn |
| NEUN: | ₹5.2mn | ₹2.7mn | 89% | ₹-33.4mn | ₹-46.9mn |
| Consolidated Total Income: | ₹11,740.2mn | ₹10,912.4mn | 8% |
Silicon Carbide Semiconductor Facility: A Strategic Milestone
A key strategic development highlighted in the investor presentation is the progress on Archean's semiconductor ambitions. The company's subsidiary, SiCSem Private Limited, conducted a Bhoomi Pujan and Groundbreaking ceremony in November 2025 to establish an integrated Silicon Carbide (SiC)-based Compound Semiconductor fab and ATMP Unit in Info Valley, Bhubaneswar, Odisha. The facility has been approved by the Cabinet under the Indian Semiconductor Mission (ISM) and is positioned as the first commercial compound fab in the country. The project is being developed in collaboration with Clas-Sic Wafer Fab Limited, UK, in which Archean Chemical holds a 21% stake.
| Parameter: | Details |
|---|---|
| Entity: | SiCSem Private Limited (step-down subsidiary of ACIL) |
| Product: | Silicon Carbide (SiC) devices – MOSFETs and Power Devices |
| Annual Wafer Capacity: | 60,000 wafers |
| Packaging Capacity: | 96 million units |
| Location: | Info Valley, Bhubaneswar, Odisha |
| Collaboration: | Clas-Sic Wafer Fab Limited, UK (ACIL holds 21% stake) |
| End Users: | Defence, EVs, Railway, Fast Chargers, Data Centres, Consumer Appliances, Solar Power Inverters |
Consolidated Balance Sheet Highlights
As of March 26, consolidated total assets stood at ₹26,647.8mn compared to ₹23,890.3mn as of March 25. Shareholders' funds increased to ₹19,343.9mn from ₹18,640.1mn. Current borrowings rose significantly to ₹2,783.5mn from ₹264.7mn, contributing to an increase in current liabilities to ₹4,383.5mn from ₹1,972.8mn. Non-current borrowings declined to ₹1,266.7mn from ₹1,516.0mn over the same period. Cash and cash equivalents stood at ₹412.3mn as of March 26 versus ₹405.4mn as of March 25.
| Balance Sheet Item: | Mar-26 | Mar-25 |
|---|---|---|
| Total Assets: | ₹26,647.8mn | ₹23,890.3mn |
| Shareholders' Funds: | ₹19,343.9mn | ₹18,640.1mn |
| Non-Current Borrowings: | ₹1,266.7mn | ₹1,516.0mn |
| Current Borrowings: | ₹2,783.5mn | ₹264.7mn |
| Cash & Cash Equivalents: | ₹412.3mn | ₹405.4mn |
| Total Equity & Liabilities: | ₹26,647.8mn | ₹23,890.3mn |
Historical Stock Returns for Archean Chemical Industries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.33% | -2.07% | -12.15% | +4.22% | -13.41% | +16.45% |
How soon could the SiCSem Silicon Carbide semiconductor facility become operational, and what revenue contribution is management projecting once it reaches full capacity of 60,000 wafers annually?
Given the sharp rise in current borrowings from ₹264.7mn to ₹2,783.5mn, what is Archean Chemical's strategy to manage its debt obligations while simultaneously funding capital-intensive semiconductor and subsidiary expansions?
With ACUME Chemicals reporting a 202% revenue surge but a deepening EBITDA loss of ₹-98.3mn, at what point does management expect the subsidiary to turn operationally profitable, and what milestones will signal a turnaround?
































